$MYCB
My City Builders, Inc.

2021 Q1 Form 10-Q Financial Statement

#000164033421001521 Filed on July 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q3 2020 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.940K $127.6K $4.380K
YoY Change -10.05% 403.35% -79.78%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.940K $127.6K $4.375K
YoY Change -9.94% 403.35% -79.8%
Operating Profit -$3.940K -$4.375K
YoY Change -9.94%
Interest Expense $15.12K -$14.50K -$70.61K
YoY Change -121.42% -79.46% -8.38%
% of Operating Profit
Other Income/Expense, Net -$15.12K -$70.61K
YoY Change -78.58%
Pretax Income -$19.06K -$142.1K -$74.99K
YoY Change -74.58% 48.07% -24.05%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$19.06K -$142.1K -$74.99K
YoY Change -74.58% 48.07% -86.12%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$238.90 -$1.781K -$939.80
COMMON SHARES
Basic Shares Outstanding 79.79M shares 79.79M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q3 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $850.00 $1.030K $1.400K
YoY Change -39.29% -44.32% -73.53%
Cash & Equivalents $845.00 $1.025K $1.400K
Short-Term Investments
Other Short-Term Assets $5.000K
YoY Change
Inventory
Prepaid Expenses $5.000K $0.00
Receivables
Other Receivables
Total Short-Term Assets $5.845K $1.025K $1.400K
YoY Change 317.5% -44.59% -99.24%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.845K $1.025K $1.400K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $5.845K $1.025K $1.400K
YoY Change 317.5% -44.59% -99.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $72.58K $52.22K
YoY Change 21.82% 92.48%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $598.9K $568.7K $512.3K
YoY Change 16.9% 53.24% 120.67%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $897.0K $854.1K $764.2K
YoY Change 17.37% 38.9% 48.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $897.0K $854.1K $764.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $897.0K $854.1K $764.2K
YoY Change 17.37% 38.9% 48.66%
SHAREHOLDERS EQUITY
Retained Earnings -$12.75M -$12.71M
YoY Change 2.91%
Common Stock $11.74M $11.74M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$891.2K -$853.0K -$762.8K
YoY Change
Total Liabilities & Shareholders Equity $5.845K $1.025K $1.400K
YoY Change 317.5% -44.59% -99.24%

Cashflow Statement

Concept 2021 Q1 2020 Q3 2020 Q1
OPERATING ACTIVITIES
Net Income -$19.06K -$142.1K -$74.99K
YoY Change -74.58% 48.07% -86.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$90.00 -$90.00 -$220.00
YoY Change -59.09% -64.0% -96.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -90.00 -90.00 -220.0
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -90.00 -90.00 -220.0
YoY Change -59.09% -64.0% -96.65%
FREE CASH FLOW
Cash From Operating Activities -$90.00 -$90.00 -$220.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56808953 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
845 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1025 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5000 USD
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
5845 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1025 USD
CY2021Q1 us-gaap Assets
Assets
5845 USD
CY2020Q3 us-gaap Assets
Assets
1025 USD
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
65776 USD
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
72576 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
212816 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
193316 USD
CY2021Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
598905 USD
us-gaap Revenues
Revenues
0 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
425 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
180 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
650 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
3850 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
3950 USD
us-gaap Professional Fees
ProfessionalFees
7700 USD
us-gaap Professional Fees
ProfessionalFees
7938 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
3940 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
4375 USD
us-gaap Operating Expenses
OperatingExpenses
7880 USD
us-gaap Operating Expenses
OperatingExpenses
8588 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3940 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4375 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7880 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8588 USD
CY2021Q1 jrvs Interest And Accretion On Convertible Notes
InterestAndAccretionOnConvertibleNotes
15123 USD
CY2020Q1 jrvs Interest And Accretion On Convertible Notes
InterestAndAccretionOnConvertibleNotes
70614 USD
jrvs Interest And Accretion On Convertible Notes
InterestAndAccretionOnConvertibleNotes
30246 USD
CY2020Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
568659 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25000000 shares
jrvs Interest And Accretion On Convertible Notes
InterestAndAccretionOnConvertibleNotes
141227 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15123 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
19500 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
15500 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
212816 USD
CY2020Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
193316 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12751207 USD
CY2021Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
19500 USD
CY2020Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
19500 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
896997 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
854051 USD
CY2021Q1 us-gaap Liabilities
Liabilities
896997 USD
CY2020Q3 us-gaap Liabilities
Liabilities
854051 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79792286 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
79792 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
79792 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11660263 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11660263 USD
CY2021Q1 jrvs Common Stock To Be Issued
CommonStockToBeIssued
120000 USD
CY2020Q3 jrvs Common Stock To Be Issued
CommonStockToBeIssued
120000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12751207 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12713081 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-891152 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-853026 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5845 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1025 USD
CY2021Q1 us-gaap Revenues
Revenues
0 USD
CY2020Q1 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70614 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30246 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-141227 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19063 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-74989 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38126 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-149815 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.12 pure
us-gaap Interest Expense
InterestExpense
12602 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
500000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
500000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
500000 USD
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
98905 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
68659 USD
CY2021Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
598905 USD
CY2020Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
568659 USD
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.05 pure
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
500000 USD
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 USD
us-gaap Interest Expense
InterestExpense
30246 USD
us-gaap Net Income Loss
NetIncomeLoss
-38126 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
128625 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-19063 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-891152 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-19063 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-74989 USD
us-gaap Net Income Loss
NetIncomeLoss
-38126 USD
us-gaap Net Income Loss
NetIncomeLoss
-149815 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79792286 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79792286 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79792286 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-853026 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-19063 USD
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79792286 shares
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
19500 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
15500 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-180 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-450 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-180 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-450 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1025 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1850 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
845 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1400 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-613027 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-687853 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-74989 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-762842 USD
us-gaap Net Income Loss
NetIncomeLoss
-38126 USD
us-gaap Net Income Loss
NetIncomeLoss
-149815 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
30246 USD
us-gaap Accretion Expense Including Asset Retirement Obligations
AccretionExpenseIncludingAssetRetirementObligations
141227 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6800 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7362 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iMine Corporation (the “Company”) is a Nevada corporation incorporated on October 26, 2010, under the name Oconn Industries. The Company’s name was changed to Oconn Industries Corp. on February 16, 2012, to Diamante Minerals, Inc. on April 1, 2014 and to iMine Corporation on March 20, 2018. The change of name to iMine Corporation was effective through the merger of the Company’s wholly owned subsidiary, iMine Corporation, into the Company. The Company has one subsidiary, iMine Corporation, an Indiana corporation, which is inactive.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s periodic filings with the SEC include, where applicable, disclosures of estimates, assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company.</p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28000000 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
22983333 shares

Files In Submission

Name View Source Status
0001640334-21-001521-index-headers.html Edgar Link pending
0001640334-21-001521-index.html Edgar Link pending
0001640334-21-001521.txt Edgar Link pending
0001640334-21-001521-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
jrvs-20210131.xsd Edgar Link pending
jrvs-20210131_cal.xml Edgar Link unprocessable
jrvs-20210131_def.xml Edgar Link unprocessable
jrvs-20210131_lab.xml Edgar Link unprocessable
jrvs-20210131_pre.xml Edgar Link unprocessable
jrvs_10q.htm Edgar Link pending
jrvs_10q_htm.xml Edgar Link completed
jrvs_ex311.htm Edgar Link pending
jrvs_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending